-
Mashup Score: 10
EYLEA HD led to improved vision with extended dosing intervals, achieving non-inferior vision gains with an every 8-week dosing regimen compared to EYLEA® (aflibercept) Injection 2 mg dosed every 4 weeks TARRYTOWN, N.Y. , Feb. 08, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc.
Source: investor.regeneron.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 7
At three years of EYLEA HD treatment, the vast majority of patients maintained visual and anatomic improvements while achieving extended dosing regimens, including those of just twice a year : 77%, 58%, 40% and 24% achieved last assigned dosing intervals of ≥3, ≥4, ≥5 and 6 months, respectively At
Source: investor.regeneron.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 9Newsroom Bayer - 5 hour(s) ago
Newsroom Bayer
Source: www.bayer.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 0
NCQA’s CCBHC Accreditation program can help states and CCBHCs prepare to meet the SAMHSA certification requirements.
Source: www.ncqa.orgCategories: General Medicine News, PayerTweet
-
Mashup Score: 0What Football Teaches Us About Fragmentation - NCQA - 1 day(s) ago
Quality improvement is a team sport. We need to move from measuring parts of the system to measuring the system as a whole.
Source: www.ncqa.orgCategories: General Medicine News, PayerTweet
-
Mashup Score: 0Statement from AMCP CEO Susan A. Cantrell on Potential Staff Cuts to Department of Health and Human Services | AMCP.org - 1 day(s) ago
Academy of Managed Care Pharmacy (AMCP) issued the following statement from AMCP CEO Susan A. Cantrell, MHL, RPh, CAE, about President Trump’s potential executive order to cut thousands of jobs at the Department of Health and Human Services:
Source: www.amcp.orgCategories: General Medicine News, PayerTweet
-
Mashup Score: 8
EMBLAVEOTM is the first and only monobactam/β-lactamase inhibitor combination antibiotic therapy approved by the U.S. FDA to treat complicated intra-abdominal infections, including those caused…
Source: news.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 0
Susan Cantrell responds to the tariffs on China, Canada, and Mexico.
Source: www.pharmexec.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 0
Objective The objective of this study is to analyse the perspectives of screening candidates and healthcare professionals on shared decision-making (SDM) in prostate cancer (PCa) screening using the prostate-specific antigen (PSA) test. Design Descriptive qualitative study (May–December 2022): six face-to-face focus groups and four semistructured interviews were conducted, transcribed verbatim and thematically analysed using ATLAS.ti software. Setting Data were obtained as part of the project PROSHADE (Decision Aid for Promoting Shared Decision Making in Opportunistic Screening for Prostate Cancer) to develop a tool for SDM in PCa screening with PSA testing in Spain. Participants A total of 27 screening candidates (three groups of men: 40–50 years old; 51–60 years old and 61–80 years old), 25 primary care professionals (one group of eight nurses and two groups of physicians: one with more and one with less than 10 years of experience), and four urologists. Focus groups for patients and
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 0
NCQA is the leader in health care accreditation. From physicians to health insurance companies, NCQA is the top health care accreditation organization.
Source: www.ncqa.orgCategories: General Medicine News, PayerTweet
Today at the Angiogenesis, Exudation, and Degeneration 2025 annual meeting, we shared the first presentation of data from our Phase 3 trial in patients with #RetinalVeinOcclusion. Read more here: https://t.co/fKVLMJVckx